Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Myungsun Shin, Ph.D.

Concepts (13)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Myungsun Shin's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Myungsun Shin has written about over time.
Animals, 1 publications between 2011 and 2011, average publication date April 2011. Gene Knockdown Techniques, 1 publications between 2011 and 2011, average publication date April 2011. Gene Silencing, 1 publications between 2011 and 2011, average publication date April 2011. Leukemia, Experimental, 1 publications between 2011 and 2011, average publication date April 2011. Male, 1 publications between 2011 and 2011, average publication date April 2011. Mice, 1 publications between 2011 and 2011, average publication date April 2011. Mice, Transgenic, 1 publications between 2011 and 2011, average publication date April 2011. Neoplasms, Experimental, 1 publications between 2011 and 2011, average publication date April 2011. Oncogene Protein v-akt, 1 publications between 2011 and 2011, average publication date April 2011. Phosphorylation, 1 publications between 2011 and 2011, average publication date April 2011. Prostatic Neoplasms, 1 publications between 2011 and 2011, average publication date April 2011. PTEN Phosphohydrolase, 1 publications between 2011 and 2011, average publication date April 2011. RNA Interference, 1 publications between 2011 and 2011, average publication date April 2011.

To see the data from this visualization as text, click here.
Shin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.